Safety and Tolerability of NIM-1324, an Oral, Once-daily LANCL2 Agonist, in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study in Normal Healthy Volunteers

被引：0
|
作者：
Leber, Andrew [1 ]
Hontecillas, Raquel [1 ]
Juni, Nuria Tubau [1 ]
Bassaganya-Riera, Josep [1 ]
机构：
[1] NIMML Inst, Blacksburg, VA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2337
引用
收藏
页码：4631 / 4632
页数：2
相关论文
共 50 条
  • [1] Safety, Tolerability, and Pharmacokinetics of NIM-1324 an Oral LANCL2 Agonist in a Randomized, Double-Blind, Placebo-Controlled Phase I Clinical Trial
    Leber, Andrew
    Hontecillas, Raquel
    Tubau-Juni, Nuria
    Bassaganya-Riera, Josep
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):
  • [2] SAFETY AND TOLERABILITY OF BT-11, A GUT-RESTRICTED LANCL2 AGONIST, IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE I STUDY IN NORMAL HEALTHY VOLUNTEERS
    Leber, Andrew
    Hontecillas, Raquel
    Zoccoli-Rodriguez, Victoria
    Colombel, Jean Frederic
    Chauhan, Jyoti
    Bassaganya-Riera, Josep
    GASTROENTEROLOGY, 2019, 156 (06) : S1112 - S1112
  • [3] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Camilo, Juan
    Ferreira, Arjona
    GASTROENTEROLOGY, 2016, 150 (04) : S537 - S538
  • [4] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [5] Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: A randomized, double-blind, placebo-controlled study
    Kahn, Rene S.
    Schulz, S. Charles
    Palazov, Veselin D.
    Reyes, Efren B.
    Brecher, Martin
    Svensson, Ola
    Andersson, Henrik M.
    Meulien, Didier
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 832 - 842
  • [6] Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
    Zuraw, Bruce
    Lumry, William R.
    Johnston, Douglas T.
    Aygoren-Pursun, Emel
    Banerji, Aleena
    Bernstein, Jonathan A.
    Christiansen, Sandra C.
    Jacobs, Joshua S.
    Sitz, Karl V.
    Gower, Richard G.
    Gagnon, Remi
    Wedner, H. James
    Kinaciyan, Tamar
    Hakl, Roman
    Hanzlikova, Jana
    Anderson, John T.
    McNeil, Donald L.
    Fritz, Stephen B.
    Yang, William H.
    Tachdjian, Raffi
    Busse, Paula J.
    Craig, Timothy J.
    Li, H. Henry
    Farkas, Henriette
    Best, Jessica M.
    Clemons, Desiree
    Cornpropst, Melanie
    Dobo, Sylvia M.
    Iocca, Heather A.
    Kargl, Deborah
    Nagy, Eniko
    Murray, Sharon C.
    Collis, Phil
    Sheridan, William P.
    Maurer, Marcus
    Riedl, Marc A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (01) : 164 - +
  • [7] Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trial
    Choi, Jong-Il
    Park, Yae Min
    Oh, Yong-Seog
    Kim, Jin-Bae
    Han, Seongwook
    Park, Jong-Sung
    On, Young Keun
    Choi, Kee-Joon
    Hwang, Gyo-Seung
    Lee, Moon-Hyoung
    Shin, Dong-Gu
    Kim, Nam-Ho
    Kim, Dae-Kyeong
    Namgung, June
    Kim, Dae-Hyeok
    Park, Hyung-Wook
    Park, Hwan-Cheol
    Choi, Eue-Keun
    Rhee, Kyoung Suk
    Shin, Seung Yong
    Kim, Young-Hoon
    HEART RHYTHM, 2024, 21 (10) : 2051 - 2052
  • [8] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
    Kong, Linghui
    Ye, Ying
    Liu, Liangang
    Reyes, Josephine
    Wan, Yuntao
    Wu, Anfan
    Lau, Henry
    Laskin, Oscar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09) : 1343 - 1343
  • [9] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE-DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS - A RANDOMIZED PLACEBO-CONTROLLED STUDY
    Zhao, Xia
    Payne, Christopher
    Wang, Feng
    Cui, Yiming
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 378 - 378
  • [10] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I Study
    Zhao, Qian
    Liu, Hongzhong
    Wang, Zhenlei
    Wang, Teng
    Cui, Cheng
    Wang, Huanhuan
    Li, Lili
    Zhong, Wen
    Jiang, Ji
    Dong, Kai
    Chen, Shuai
    Jin, Chunyan
    Hu, Pei
    ADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198
12345